© 2026 Stocks Telegraph All rights reserved.
Most stock quote data provided by Financial Modeling Prep
Quest Diagnostics Incorporated (DGX) stock surged +3.01%, trading at $203.11 on NYSE, up from the previous close of $197.18. The stock opened at $198.41, fluctuating between $198.41 and $205.76 in the recent session.
| Filing Date | Accepted Date | |
|---|---|---|
| Filing Date | Accepted Date | |
|---|---|---|
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Jun 24, 2026 | 198.41 | 205.76 | 198.41 | 203.11 | 1.03M |
| Jun 23, 2026 | 195.78 | 197.79 | 194.15 | 197.18 | 957.74K |
| Jun 22, 2026 | 194.13 | 195.16 | 192.90 | 193.58 | 879.35K |
| Jun 18, 2026 | 196.69 | 197.44 | 192.83 | 195.00 | 1.29M |
| Jun 17, 2026 | 200.00 | 201.04 | 196.50 | 197.76 | 754.15K |
| Jun 16, 2026 | 203.03 | 204.70 | 199.66 | 201.04 | 1.01M |
| Jun 15, 2026 | 202.25 | 203.20 | 200.37 | 202.18 | 1.01M |
| Jun 12, 2026 | 205.53 | 205.96 | 202.38 | 203.06 | 887.94K |
| Jun 11, 2026 | 204.07 | 207.50 | 202.54 | 203.83 | 1.05M |
| Jun 10, 2026 | 203.35 | 207.30 | 202.97 | 203.78 | 761.42K |
| Jun 09, 2026 | 197.90 | 204.84 | 196.99 | 204.53 | 743.87K |
| Jun 08, 2026 | 202.08 | 202.08 | 196.70 | 197.21 | 772.59K |
| Jun 05, 2026 | 197.41 | 201.54 | 197.31 | 200.29 | 787.41K |
| Jun 04, 2026 | 194.99 | 201.99 | 194.99 | 196.12 | 731.48K |
| Jun 03, 2026 | 193.00 | 195.21 | 192.38 | 193.67 | 418.64K |
| Jun 01, 2026 | 194.14 | 196.48 | 191.85 | 192.20 | 603.04K |
| May 29, 2026 | 196.59 | 197.38 | 194.30 | 194.90 | 1.23M |
| May 28, 2026 | 194.03 | 196.80 | 193.91 | 196.20 | 644.85K |
| May 27, 2026 | 194.26 | 196.32 | 192.57 | 193.99 | 597.16K |
| May 26, 2026 | 194.26 | 194.69 | 192.35 | 192.88 | 869.41K |
Quest Diagnostics Incorporated, founded in 1967 and headquartered in Secaucus, New Jersey, is a premier provider of diagnostic testing, information, and related services, serving clients both domestically and internationally. Its core business involves the development and provision of diverse diagnostic information services, such as routine, advanced clinical, and anatomic pathology testing. While primarily operating under the Quest Diagnostics brand, it also leverages specialized identities like AmeriPath, Dermpath Diagnostics, ExamOne, and Quanum to reach a broad spectrum of clients. Its extensive client base includes patients, clinicians, hospitals, integrated delivery networks, health plans, employers, and other direct healthcare entities. Delivery of these services is facilitated through a robust network comprising laboratories, patient service centers, in-office phlebotomists, call centers, and mobile health professionals including paramedics and nurses. Additionally, the company provides risk assessment services for the life insurance industry and offers comprehensive information technology solutions to healthcare organizations and clinicians.
| Employees | 55000 |
| Beta | 0.59 |
| Sales or Revenue | $9.87B |
| 5Y Sales Change% | 0.492% |
| Fiscal Year Ends | December |
| Sector | Healthcare |
| Industry | Medical - Diagnostics & Research |